Marko Lehtonen

5.4k total citations
151 papers, 4.0k citations indexed

About

Marko Lehtonen is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Marko Lehtonen has authored 151 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 34 papers in Pharmacology and 27 papers in Physiology. Recurrent topics in Marko Lehtonen's work include Metabolomics and Mass Spectrometry Studies (28 papers), Cannabis and Cannabinoid Research (21 papers) and Diet and metabolism studies (15 papers). Marko Lehtonen is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (28 papers), Cannabis and Cannabinoid Research (21 papers) and Diet and metabolism studies (15 papers). Marko Lehtonen collaborates with scholars based in Finland, Sweden and United Kingdom. Marko Lehtonen's co-authors include Kati Hanhineva, Kai Kaarniranta, Antero Salminen, Seppo Auriola, Juhani Huuskonen, Tiina Suuronen, Tuomas Paimela, Matti Uusitupa, Vanessa D. de Mello and Pekka Keski‐Rahkonen and has published in prestigious journals such as PLoS ONE, Biomaterials and American Journal of Clinical Nutrition.

In The Last Decade

Marko Lehtonen

145 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marko Lehtonen Finland	32	1.8k	801	717	442	312	151	4.0k
Rosalba Siracusa Italy	48	1.8k 1.0×	925 1.2×	1.2k 1.7×	367 0.8×	389 1.2×	171	5.8k
Irene Paterniti Italy	44	1.9k 1.1×	733 0.9×	641 0.9×	477 1.1×	483 1.5×	191	5.1k
Marika Cordaro Italy	49	1.6k 0.9×	846 1.1×	1.1k 1.6×	340 0.8×	400 1.3×	185	5.4k
Michele Navarra Italy	52	2.0k 1.1×	556 0.7×	726 1.0×	374 0.8×	317 1.0×	161	6.5k
Vincenzo Calderone Italy	44	2.8k 1.6×	1.2k 1.5×	427 0.6×	406 0.9×	375 1.2×	258	6.9k
Daniel Pens Gelain Brazil	41	2.0k 1.1×	797 1.0×	436 0.6×	416 0.9×	160 0.5×	185	5.7k
Gioacchino Calapai Italy	50	1.3k 0.7×	970 1.2×	893 1.2×	460 1.0×	348 1.1×	173	6.4k
Roberta Fusco Italy	41	1.4k 0.8×	614 0.8×	704 1.0×	246 0.6×	336 1.1×	152	4.2k
Silvana Hrelia Italy	47	2.9k 1.7×	1.2k 1.5×	601 0.8×	307 0.7×	393 1.3×	194	7.0k
Fariba Khodagholi Iran	37	1.9k 1.1×	1.2k 1.5×	617 0.9×	768 1.7×	268 0.9×	262	5.3k

Countries citing papers authored by Marko Lehtonen

Since Specialization

Citations

This map shows the geographic impact of Marko Lehtonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Lehtonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Lehtonen more than expected).

Fields of papers citing papers by Marko Lehtonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Lehtonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Lehtonen. The network helps show where Marko Lehtonen may publish in the future.

Co-authorship network of co-authors of Marko Lehtonen

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Lehtonen. A scholar is included among the top collaborators of Marko Lehtonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Lehtonen. Marko Lehtonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehtonen, Marko, et al.. (2025). Unraveled cancer cell survival-associated amino acid metabolism of HepG2 cells altered by Thai rat-tailed radish microgreen extract examined by untargeted LC-MS/MS analysis. Food Chemistry. 474. 143206–143206. 1 indexed citations

Lehtonen, Marko, et al.. (2025). Alterations in the Plasma Metabolome Associated With Maternal Smoking During the First Trimester and Foetal Growth. Basic & Clinical Pharmacology & Toxicology. 136(5). e70037–e70037. 1 indexed citations

Lehtonen, Marko, Mika Martiskainen, Jari Tiihonen, et al.. (2025). Metabolic Alterations in Human Post‐Mortem Frontal Cortex and Cerebrospinal Fluid Associated With High Levels of Nicotine Metabolite Cotinine. Addiction Biology. 30(6). e70064–e70064.

Babu, Ambrin Farizah, Vesa Kärjä, Marko Lehtonen, et al.. (2024). Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients. Digestive and Liver Disease. 56(12). 2103–2110. 5 indexed citations

Neuvonen, Mikko, et al.. (2024). Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and Translational Science. 17(3). e13773–e13773. 3 indexed citations

Juvonen, Risto O., et al.. (2024). Anthraquinone biocolourant dermocybin is metabolized whereas dermorubin is not in in vitro liver fractions and recombinant metabolic enzymes. Basic & Clinical Pharmacology & Toxicology. 134(6). 846–857.

Noerman, Stefania, Anna Johansson, Lin Shi, et al.. (2024). Fasting plasma metabolites reflecting meat consumption and their associations with incident type 2 diabetes in two Swedish cohorts. American Journal of Clinical Nutrition. 119(5). 1280–1292. 3 indexed citations

Lehtonen, Marko, Pekka Keski‐Rahkonen, Thomas M. O’Connell, et al.. (2023). Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease. mBio. 14(1). e0266322–e0266322. 27 indexed citations

Noerman, Stefania, Jyrki K. Virtanen, Marko Lehtonen, Carl Brunius, & Kati Hanhineva. (2022). Serum metabolites associated with wholegrain consumption using nontargeted metabolic profiling: a discovery and reproducibility study. European Journal of Nutrition. 62(2). 713–726. 4 indexed citations

10.

Markowicz-Piasecka, Magdalena, et al.. (2021). Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP). International Journal of Molecular Sciences. 22(14). 7727–7727. 9 indexed citations

11.

Kärkkäinen, Olli, Anton Klåvus, Ari Voutilainen, et al.. (2020). Changes in Circulating Metabolome Precede Alcohol‐Related Diseases in Middle‐Aged Men: A Prospective Population‐Based Study With a 30‐Year Follow‐Up. Alcoholism Clinical and Experimental Research. 44(12). 2457–2467. 10 indexed citations

12.

Löffler, Susanne, Johanna Huttunen, Seppo Auriola, et al.. (2020). L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood–Brain Barrier and into Human and Mouse Brain Parenchymal Cells. ACS Chemical Neuroscience. 11(24). 4301–4315. 46 indexed citations

13.

Mello, Vanessa D. de, Maria Lankinen, Jaana Lindström, et al.. (2017). Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations

14.

Kokki, Merja, Heidi Hautajärvi, Marko Lehtonen, et al.. (2016). The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty. Clinical Drug Investigation. 36(7). 545–555. 9 indexed citations

15.

Navia‐Paldanius, Dina, Niina Aaltonen, Marko Lehtonen, et al.. (2015). Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase. European Journal of Pharmaceutical Sciences. 77. 180–188. 23 indexed citations

16.

Hanhineva, Kati, Maria Lankinen, Anna Pedret, et al.. (2014). Nontargeted Metabolite Profiling Discriminates Diet-Specific Biomarkers for Consumption of Whole Grains, Fatty Fish, and Bilberries in a Randomized Controlled Trial. Journal of Nutrition. 145(1). 7–17. 133 indexed citations

17.

Muguruza, Carolina, Marko Lehtonen, Niina Aaltonen, et al.. (2013). Quantification of endocannabinoids in postmortem brain of schizophrenic subjects. Schizophrenia Research. 148(1-3). 145–150. 64 indexed citations

18.

Keski‐Rahkonen, Pekka, et al.. (2008). Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography–electrospray tandem mass spectrometry. Journal of Chromatography B. 876(2). 191–197. 23 indexed citations

19.

Kokki, Merja, Marko Lehtonen, Merja Laisalmi, et al.. (2007). Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children. PEDIATRICS. 120(4). e1002–e1008. 30 indexed citations

20.

Mäkelä, Riikka, Marko Lehtonen, William Wisden, Hartmut Lüddens, & Esa R. Korpi. (1996). Blunted Furosemide Action On Cerebellar GABA A Receptors In ANT Rats Selectively Bred for High Alcohol Sensitivity. Neuropharmacology. 35(9-10). 1493–1502. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact